monofluoroquinolones | CMAC

monofluoroquinolones

Safety of Monofluoroquinolones in Pediatric Patients

Two groups of children on therapy with monofluoroquinolones were enrolled in this open trial: 169 patients with cystic fibrosis (exacerbation period) and 55 patients with aplastic anemia (neutropenic phase); age was from 6 months to 16 years. The aim …